Stocks Overview

LAST PRICE
27.5350
TODAY'S CHANGE (%)
Trending Down-0.4550 (-1.6256%)

Bid / Lots
27.5000/ 4
Ask / Lots
28.1500/ 2
Open / Previous Close
28.1700 / 27.9900
Day Range
Low 27.5200
High 28.1700
52 Week Range
Low 25.2000
High 31.6550
Volume
5,797,140
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 27.99
Time	Volume	RPRX
09:32 ET	82332	28.0028
09:34 ET	6253	27.94
09:36 ET	4688	27.88
09:38 ET	5460	27.93
09:39 ET	5337	27.96
09:41 ET	2659	27.98
09:43 ET	2708	27.96
09:45 ET	3943	27.92
09:48 ET	9032	27.84
09:50 ET	3939	27.87
09:52 ET	5127	27.86
09:54 ET	5640	27.78
09:56 ET	4408	27.72
09:57 ET	4118	27.73
09:59 ET	1659	27.71
10:01 ET	3344	27.775
10:03 ET	3106	27.735
10:06 ET	12625	27.71
10:08 ET	4229	27.695
10:10 ET	5616	27.705
10:12 ET	4500	27.69
10:14 ET	1883	27.705
10:15 ET	1362	27.69
10:17 ET	5700	27.69
10:19 ET	4592	27.71
10:21 ET	4172	27.725
10:24 ET	1105	27.73
10:26 ET	1755	27.74
10:28 ET	3663	27.73
10:30 ET	2377	27.73
10:32 ET	10265	27.735
10:33 ET	200	27.735
10:35 ET	4414	27.775
10:37 ET	5155	27.7642
10:39 ET	6660	27.795
10:42 ET	5319	27.7811
10:44 ET	3060	27.785
10:46 ET	4168	27.77
10:48 ET	830	27.79
10:50 ET	800	27.795
10:51 ET	1684	27.82
10:53 ET	2007	27.85
10:55 ET	6418	27.85
10:57 ET	1859	27.85
11:00 ET	3657	27.865
11:02 ET	2074	27.84
11:04 ET	300	27.845
11:06 ET	2210	27.845
11:08 ET	5085	27.85
11:09 ET	1245	27.855
11:11 ET	2299	27.85
11:13 ET	3683	27.8401
11:15 ET	4472	27.83
11:18 ET	1174	27.835
11:20 ET	5539	27.845
11:22 ET	200	27.85
11:24 ET	6373	27.83
11:26 ET	2903	27.815
11:27 ET	4309	27.825
11:29 ET	2951	27.84
11:31 ET	3205	27.865
11:33 ET	4235	27.8476
11:36 ET	2097	27.86
11:38 ET	5281	27.865
11:40 ET	588	27.875
11:42 ET	1814	27.865
11:44 ET	2821	27.875
11:45 ET	300	27.88
11:47 ET	3389	27.87
11:49 ET	2441	27.875
11:51 ET	300	27.845
11:54 ET	600	27.84
11:56 ET	163	27.8311
11:58 ET	4395	27.83
12:00 ET	2289	27.81
12:02 ET	306	27.815
12:03 ET	2813	27.81
12:07 ET	13649	27.795
12:09 ET	4142	27.81
12:12 ET	1430	27.805
12:14 ET	932	27.805
12:16 ET	4017	27.795
12:18 ET	2308	27.795
12:20 ET	1600	27.795
12:21 ET	7660	27.81
12:23 ET	2232	27.815
12:25 ET	4063	27.795
12:27 ET	3549	27.835
12:30 ET	2241	27.8
12:32 ET	753	27.8
12:34 ET	600	27.82
12:36 ET	200	27.825
12:38 ET	2810	27.845
12:39 ET	4795	27.845
12:41 ET	600	27.845
12:43 ET	2185	27.835
12:45 ET	2737	27.84
12:48 ET	3740	27.825
12:50 ET	200	27.825
12:52 ET	3678	27.81
12:54 ET	200	27.815
12:56 ET	3504	27.83
12:57 ET	600	27.825
12:59 ET	35227	27.775
01:01 ET	4341	27.77
01:03 ET	1510	27.775
01:06 ET	700	27.775
01:08 ET	11709	27.805
01:10 ET	8466	27.7911
01:12 ET	1100	27.8
01:14 ET	3364	27.805
01:15 ET	2936	27.8
01:17 ET	5702	27.81
01:19 ET	800	27.815
01:21 ET	1933	27.815
01:24 ET	8289	27.805
01:26 ET	5844	27.815
01:28 ET	700	27.815
01:30 ET	4129	27.795
01:32 ET	5383	27.805
01:33 ET	8663	27.805
01:35 ET	1234	27.805
01:37 ET	3335	27.815
01:39 ET	497	27.815
01:42 ET	2056	27.815
01:44 ET	5929	27.815
01:46 ET	3509	27.825
01:48 ET	1498	27.83
01:50 ET	500	27.825
01:51 ET	2511	27.835
01:53 ET	2240	27.835
01:55 ET	9901	27.8229
01:57 ET	8886	27.8
02:00 ET	3840	27.81
02:02 ET	3058	27.8
02:04 ET	1980	27.795
02:06 ET	13980	27.805
02:08 ET	4932	27.805
02:09 ET	1123	27.805
02:11 ET	4277	27.805
02:13 ET	1526	27.815
02:15 ET	3862	27.815
02:18 ET	4015	27.815
02:20 ET	1100	27.81
02:22 ET	11922	27.815
02:24 ET	5260	27.805
02:26 ET	900	27.805
02:27 ET	1400	27.805
02:29 ET	1000	27.805
02:31 ET	9941	27.785
02:33 ET	8481	27.795
02:36 ET	3991	27.815
02:38 ET	883	27.82
02:40 ET	1324	27.815
02:42 ET	7098	27.81
02:44 ET	15910	27.818
02:45 ET	3000	27.82
02:47 ET	3600	27.845
02:49 ET	4350	27.865
02:51 ET	2831	27.855
02:54 ET	3440	27.875
02:56 ET	11581	27.835
02:58 ET	7878	27.845
03:00 ET	5064	27.83
03:02 ET	9364	27.815
03:03 ET	1491	27.815
03:05 ET	11938	27.795
03:07 ET	10478	27.799
03:09 ET	5819	27.8
03:12 ET	23326	27.77
03:14 ET	1796	27.755
03:16 ET	2577	27.765
03:18 ET	923	27.765
03:20 ET	6884	27.77
03:21 ET	8612	27.7567
03:23 ET	3177	27.775
03:25 ET	852	27.765
03:27 ET	4384	27.775
03:30 ET	1920	27.76
03:32 ET	3892	27.745
03:34 ET	3083	27.745
03:36 ET	8607	27.725
03:38 ET	1622	27.705
03:39 ET	3385	27.71
03:41 ET	7179	27.685
03:43 ET	5955	27.685
03:45 ET	4526	27.695
03:48 ET	6612	27.68
03:50 ET	14950	27.705
03:52 ET	39929	27.635
03:54 ET	18442	27.65
03:56 ET	34933	27.605
03:57 ET	70786	27.615
03:59 ET	2634038	27.535

Data delayed at least 15 minutes.

Today
- DJ S&P 500 Futures Decline In Premarket Trading; FedEx, Frontline Lag, from 11 hours ago by Dow Jones
  11 hours ago by Dow Jones
Sep 18, 2024
- DJ S&P 500 Futures Up In Premarket Trading; Manhattan Associates, Casella Waste Sys Lag, from 7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
  7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 3, 2024
- Press Release: Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
- Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
- Press Release: Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement, from 5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones
  5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRPRX Royalty Pharma PLC	16.6B	18.3x	+1.83%
United StatesAMRX Amneal Pharmaceuticals Inc	2.7B	-14.0x	---
United StatesNDOI Endo Inc	2.0B	0.4x	---
United StatesCTLT Catalent Inc	10.9B	-10.4x	---
United StatesJAZZ Jazz Pharmaceuticals PLC	6.9B	19.0x	-3.53%
United StatesMCKPF Mallinckrodt PLC	1.6M	0.0x	---
As of 2024-09-20

Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.

Contact Information

Headquarters: 110 East 59th StreetNEW YORK, NY, United States 10022
Phone: 212-883-0200
Fax: ---

Executives

Chairman of the Board, Chief Executive Officer: Pablo Legorreta
Vice Chairman, Executive Vice President: Christopher Hite
Chief Financial Officer, Executive Vice President: Terrance Coyne
Executive Vice President - Investments and Chief Legal Officer: George Lloyd
Executive Vice President - Head of Human Capital: Molly Sawaya

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$16.6B
Revenue (TTM)	$2.2B
Shares Outstanding	593.5M
Dividend Yield	3.05%
Annual Dividend Rate	0.8400 USD
Ex-Dividend Date	08-16-24
Pay Date	09-13-24
Beta	0.46
EPS	$1.50
Book Value	$14.61
P/E Ratio	18.3x
Price/Sales (TTM)	7.4
Price/Cash Flow (TTM)	19.8x
Operating Margin	42.91%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Royalty Pharma PLC
NASDAQ:RPRXUnited States

Search Criteria

Charts

Recent News

Today

DJ S&P 500 Futures Decline In Premarket Trading; FedEx, Frontline Lag, from 11 hours ago by Dow Jones

Sep 18, 2024

DJ S&P 500 Futures Up In Premarket Trading; Manhattan Associates, Casella Waste Sys Lag, from 7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones

Sep 3, 2024

Press Release: Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones

Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones

Press Release: Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement, from 5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar